NEW YORK (GenomeWeb News) – Response Genetics today said that it has received the third milestone payment from GlaxoSmithKline related to a licensing agreement reached by the two firms in March 2010.

Response Genetics received the milestone payment of $500,000 upon notice by the US Patent and Trademark Office that its patent titled "Methods, primers, Probes, and Kits Useful for the Detection of BRAF Mutations" has been allowed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.